Barings’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,932
| Closed | -$237K | – | 196 |
|
|
2022
Q3 | $237K | Sell |
2,932
-8,213
| -74% | -$738K | 0.01% | 171 |
|
|
2022
Q2 | $1M | Buy |
11,145
+1,138
| +11% | +$115K | 0.04% | 158 |
|
|
2022
Q1 | $1.11M | Buy |
10,007
+499
| +5% | +$52.7K | 0.03% | 165 |
|
|
2021
Q4 | $984K | Sell |
9,508
-432
| -4% | -$50K | 0.03% | 194 |
|
|
2021
Q3 | $1.25M | Buy |
9,940
+1,638
| +20% | +$212K | 0.03% | 174 |
|
|
2021
Q2 | $1.03M | Sell |
8,302
-898
| -10% | -$113K | 0.02% | 210 |
|
|
2021
Q1 | $1.09M | Sell |
9,200
-155
| -2% | -$18.2K | 0.03% | 217 |
|
|
2020
Q4 | $1.1M | Sell |
9,355
-6,978
| -43% | -$768K | 0.03% | 220 |
|
|
2020
Q3 | $1.7M | Sell |
16,333
-2,057
| -11% | -$207K | 0.04% | 263 |
|
|
2020
Q2 | $1.66M | Hold |
18,390
| – | – | 0.06% | 217 |
|
|
2020
Q1 | $1.66M | Buy |
18,390
+4,438
| +32% | +$472K | 0.06% | 217 |
|
|
2019
Q4 | $1.58M | Sell |
13,952
-9,133
| -40% | -$1M | 0.04% | 278 |
|
|
2019
Q3 | $2.51M | Buy |
23,085
+14
| +0.1% | +$1.46K | 0.06% | 222 |
|
|
2019
Q2 | $2.25M | Sell |
23,071
-1,457
| -6% | -$133K | 0.05% | 240 |
|
|
2019
Q1 | $2.23M | Sell |
24,528
-17,500
| -42% | -$1.57M | 0.05% | 258 |
|
|
2018
Q4 | $3.82M | Hold |
42,028
| – | – | 0.07% | 166 |
|
|
2018
Q3 | $4.13M | Sell |
42,028
-19,200
| -31% | -$1.78M | 0.06% | 200 |
|
|
2018
Q2 | $5.24M | Sell |
61,228
-7,657
| -11% | -$640K | 0.07% | 180 |
|
|
2018
Q1 | $5.53M | Hold |
68,885
| – | – | 0.08% | 173 |
|
|
2017
Q4 | $5.56M | Buy |
68,885
+32,000
| +87% | +$2.56M | 0.07% | 189 |
|
|
2017
Q3 | $2.87M | Sell |
36,885
-13,200
| -26% | -$1.1M | 0.05% | 241 |
|
|
2017
Q2 | $4.45M | Sell |
50,085
-25,243
| -34% | -$2.13M | 0.13% | 138 |
|
|
2017
Q1 | $6.07M | Buy |
75,328
+39,043
| +108% | +$3.05M | 0.07% | 276 |
|
|
2016
Q4 | $2.58M | Sell |
36,285
-12,400
| -25% | -$974K | 0.06% | 214 |
|
|
2016
Q3 | $4.21M | Buy |
48,685
+9,000
| +23% | +$784K | 0.11% | 112 |
|
|
2016
Q2 | $3.44M | Sell |
39,685
-48,200
| -55% | -$3.9M | 0.09% | 152 |
|
|
2016
Q1 | $6.59M | Buy |
87,885
+200
| +0.2% | +$15.1K | 0.18% | 74 |
|
|
2015
Q4 | $6.75M | Buy |
87,685
+7,300
| +9% | +$550K | 0.17% | 70 |
|
|
2015
Q3 | $5.38M | Sell |
80,385
-40,632
| -34% | -$2.99M | 0.13% | 97 |
|
|
2015
Q2 | $8.97M | Sell |
121,017
-61,600
| -34% | -$4.71M | 0.27% | 68 |
|
|
2015
Q1 | $14.2M | Buy |
182,617
+72,900
| +66% | +$5.53M | 0.33% | 35 |
|
|
2014
Q4 | $7.92M | Hold |
109,717
| – | – | 0.17% | 82 |
|
|
2014
Q3 | $6.8M | Hold |
109,717
| – | – | 0.15% | 100 |
|
|
2014
Q2 | $7M | Buy |
109,717
+3,300
| +3% | +$200K | 0.21% | 105 |
|
|
2014
Q1 | $6.55M | Sell |
106,417
-22,600
| -18% | -$1.32M | 0.21% | 102 |
|
|
2013
Q4 | $7.4M | Buy |
129,017
+15,900
| +14% | +$902K | 0.31% | 67 |
|
|
2013
Q3 | $6.02M | Sell |
113,117
-28,400
| -20% | -$1.53M | 0.26% | 85 |
|
|
2013
Q2 | $7.28M | Buy |
+141,517
| New | +$7M | 0.33% | 64 |
|
Other funds holding MDT
Barings's MDT Position: Q4 2022 in Review
Barings sold out of Medtronic (MDT) in Q4 2022, closing a stake of 2,932 shares — an estimated $237K sold.
Barings first reported a position in MDT in Q2 2013 and held it in 38 quarters. The position peaked at $14.2M in Q1 2015. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.
- Barings reported no remaining Medtronic position as of Q4 2022 after selling out during the quarter.
- Barings sold 2,932 Medtronic shares in Q4 2022, an estimated $237K.
- Barings first reported a position in Medtronic in Q2 2013 and held it in 38 quarters.
- Barings's Medtronic position peaked at $14.2M in Q1 2015.
- 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.
Based on Barings's 13F filing for Q4 2022, filed 13 Feb 2023.